Nasdaq, Inc. logo NDAQ - Nasdaq, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 22
HOLD 13
SELL 1
STRONG
SELL
0
| PRICE TARGET: $114.60 DETAILS
HIGH: $120.00
LOW: $109.00
MEDIAN: $115.00
CONSENSUS: $114.60
UPSIDE: 25.92%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 80% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Strong
Trading 45.9% above fair value
Current Price $91.01
Bear Case $40.92 55.0% downside ($40.92 - $91.01) / $91.01 = -55.0% ROTCE 11.0% → 1.21x TBV
Fair Value $62.39 31.5% downside ($62.39 - $91.01) / $91.01 = -31.5% ROTCE 14.6% → 1.85x TBV
Bull Case $75.27 17.3% downside ($75.27 - $91.01) / $91.01 = -17.3% ROTCE 16.8% → 2.23x TBV

Adjust Assumptions

14.6%
9.7%

Key Value Driver

ROTCE (14.6%) vs. cost of equity (9.7%)

Implied Market Multiple 4.21x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $114.60 from 36 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $62.39 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $114.60 (from 36 analysts). Our estimate is 65% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly